The DOI matches its Crossref record.
Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India
Abstract
Sir, The production of carbapenemases is the most common mechanism responsible for carbapenem resistance in Acinetobacter baumannii. They include metallo-β-lactamases (VIM, IMP and SIM types), which have been sporadically reported in some parts of the world, and acquired OXA-type carbapenemases which have been more frequently identified worldwide and are clustered in three major subfamilies (blaOXA-23, blaOXA-24 and blaOXA-58).1 High levels of resistance to aminoglycosides due to the production of plasmid-encoded 16S rRNA methylase in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp. have been documented since 2003.2 The present study was undertaken to determine the mechanism responsible for the carbapenem resistance. Three carbapenem-non-susceptible A. baumannii were isolated from patients in the intensive care unit of a tertiary care hospital in Chennai, India in April 2010. Species identification and antibiotic testing were carried out using an automated machine (VITEK-2). The MICs of carbapenems and aminoglycosides were determined using the CLSI agar dilution method, while tigecycline MICs were determined using the EUCAST broth microdilution method. All the isolates were resistant to all the β-lactams, aminoglycosides and quinolones, and were only susceptible to tigecycline and colistin. Double disc synergy test (DDST) and modified Hodge test (MHT) were used for detection of metallo-β-lactamases and other carbapenemases, respectively. PCR screening was performed for OXA-type carbapenemases (blaOXA-23, -24, -51 and -58-like) and the known metallo-β-lactamase genes.3–5 All three isolates showed positivity for both DDST and MHT, and PCR yielded the products with expected sizes for blaOXA-51, 23-like and blaNDM-1 (Table 1). Sequencing of both blaOXA-23 and blaNDM-1 genes showed 100% identities with previously reported genes. In all three isolates, the blaOXA-23 gene was adjacent to insertion element ISAba1, which provides the promoter required for expression of linked resistance genes; blaOXA-51-like genes were also found in all of the isolates, but were not activated by ISAba1. Conjugation experiments using Escherichia coli J53 as the recipient were unsuccessful. Plasmids of Enterobacteriaceae were not detected among A. baumannii by PCR-based replicon typing.6 Analysis of the three A. baumannii by MIC, DDST, MHT and PCR for resistance determinants IPM, imipenem; MEM, meropenem; AMK, amikacin; GEN, gentamicin; NET, netilmicin; TOB, tobramycin; TGC, tigecycline; DDST, double disc synergy test; MHT, modified Hodge test. Analysis of the three A. baumannii by MIC, DDST, MHT and PCR for resistance determinants IPM, imipenem; MEM, meropenem; AMK, amikacin; GEN, gentamicin; NET, netilmicin; TOB, tobramycin; TGC, tigecycline; DDST, double disc synergy test; MHT, modified Hodge test. Susceptibility testing showed increased MICs of carbapenems and an unusual phenotype of broad-spectrum high-level resistance to aminoglycosides, including amikacin, gentamicin, netilmicin and tobramycin (MICs > 256 mg/L), with susceptibility to tigecycline (MIC = 0.5–1 mg/L). PCR screening was performed for 16S rRNA methylase-encoding genes (armA, rmtA, rmtB, rmtC, rmtD and npmA).2,7–9 All three isolates showed positivity for the armA gene (Table 1). NDM-1 metallo-β-lactamase-mediated resistance to carbapenems in Enterobacteriaceae has been found in many parts of India.5,10,11 However, to our knowledge, this is the first report of the coexistence of the blaOXA-23 gene with blaNDM-1 and armA in clinical isolates of A. baumannii in India. A. baumannii isolates have been found to carry mixed carbapenemase genes giving very broad-spectrum antibiotic resistance profiles. The emergence of these powerful coexistent resistance mechanisms described here will further seriously limit future therapeutic options. This study was supported by the University Grant Commission, New Delhi, India. None to declare.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Multiplex PCR for detection of acquired carbapenemase genes
Poirel, L., Walsh, T. R., Cuvillier, V., & Nordmann, P. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.12.002 · Cited by 1,991
Walsh, T. R., Weeks, J., Livermore, D. M., & Toleman, M. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70059-7 · Cited by 1,250
Lee, C.-R., Lee, J. H., Park, M., Park, K. S., Bae, I. K., Kim, Y. B., Cha, C.-J., Jeong, B. C., & Lee, S. H. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00055 · Cited by 1,016
An omics-based framework for assessing the health risk of antimicrobial resistance genes
Zhang, A.-N., Gaston, J. M., Dai, C. L., Zhao, S., Poyet, M., Groussin, M., Yin, X., Li, L.-G., van Loosdrecht, M. C. M., Topp, E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25096-3 · Cited by 939
Woodford, N., Turton, J. F., & Livermore, D. M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00268.x · Cited by 885
Potron, A., Poirel, L., & Nordmann, P. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.03.001 · Cited by 688
.Wyres, K. L., & Holt, K. E. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2018.04.004 · Cited by 685
The emerging NDM carbapenemases
Nordmann, P., Poirel, L., Walsh, T. R., & Livermore, D. M. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.09.005 · Cited by 663
Hospital Epidemiology and Infection Control in Acute-Care Settings
Sydnor, E. R. M., & Perl, T. M. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00027-10 · Cited by 652
“NDM-1 has already been reported in other Enterobacteriaceae and nonEnterobacteriaceae Gram-negative organisms from around the world (53, 165, 175, 220).”
BackgroundMetallo-β-lactamases: a last frontier for β-lactams?
Cornaglia, G., Giamarellou, H., & Rossolini, G. M. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70056-1 · Cited by 613
Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives
Garneau-Tsodikova, S., & Labby, K. J. (2016) · MedChemComm · doi:10.1039/c5md00344j · Cited by 576
Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages
Zarrilli, R., Pournaras, S., Giannouli, M., & Tsakris, A. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.09.008 · Cited by 496
Aminoglycoside Antibiotics in the 21st Century
Becker, B., & Cooper, M. A. (2013) · ACS Chemical Biology · doi:10.1021/cb3005116 · Cited by 419
Bush, K., & Fisher, J. F. (2011) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090110-102911 · Cited by 419
Johnson, A. P., & Woodford, N. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.052555-0 · Cited by 411
Kempf, M., & Rolain, J.-M. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.10.004 · Cited by 389
Nordmann, P., Poirel, L., Carrër, A., Toleman, M. A., & Walsh, T. R. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01773-10 · Cited by 370
The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace
Roca, I., Espinal, P., Vila-Farrés, X., & Vila, J. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00148 · Cited by 363
Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside
Lin, M.-F. (2014) · World Journal of Clinical Cases · doi:10.12998/wjcc.v2.i12.787 · Cited by 357
Asif, M., Alvi, I. A., & Rehman, S. U. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s166750 · Cited by 333
Nordmann, P., Poirel, L., Toleman, M. A., & Walsh, T. R. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq520 · Cited by 294
Hammoudi Halat, D., & Ayoub Moubareck, C. (2020) · Antibiotics · doi:10.3390/antibiotics9040186 · Cited by 287
Emergence of NDM-1-producing Acinetobacter baumannii in China
Chen, Y., Zhou, Z., Jiang, Y., & Yu, Y. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr082 · Cited by 271
Karah, N., Sundsfjord, A., Towner, K., & Samuelsen, Ø. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.06.001 · Cited by 264
Escalating antimicrobial resistance among Enterobacteriaceae: Focus on carbapenemases
Lynch, J. P., Clark, N. M., & Zhanel, G. G. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1904891 · Cited by 58
Metadata
- Authors
- Karthikeyan, K., Thirunarayan, M. A., & Krishnan, P.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-07-21
- Volume
- 65
- Issue
- 10
- Pages
- 2253-2254
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W1968507574
- Cited by
- 243
- References
- 0
- FWCI
- 13.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.